Afatinib in NSCLC With HER2 Mutation
Clinical trial NCT02369484 · COMPLETED
Trial details
- NCT number
- NCT02369484
- Sponsor
- ETOP IBCSG Partners Foundation
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-09-16
- Primary completion
- 2017-09-15
- Enrollment
- 13
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.